Navigation Links
Bradmer to present at Rodman & Renshaw Healthcare Conference
Date:11/3/2008

TSX: BMR

TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, announced today that Dr. Alan M. Ezrin, President and Chief Executive Officer of the Company, will present a corporate update at Rodman & Renshaw 10th Annual Healthcare Conference, which is being held in New York City from November 10th - 12th at the New York Palace Hotel. Dr. Ezrin will provide an update on the Company's ongoing GLASS-ART(TM) Trial, a Phase III study evaluating Neuradiab(TM) as an adjunct therapy to the current standard of care for newly diagnosed glioblastoma multiforme (GBM). The presentation will take place on Wednesday, November 12th at 10:45am ET in the Kennedy I Room and Dr. Ezrin will be available for questions following his presentation.

About the GLASS-ART Trial (http://www.glassarttrial.com)

The Phase III GLASS-ART Trial derives its name from its description: GBM Locoregional Agent Survival Study - Antitenascin Radiolabeled antibody Therapy Trial. The study is designed to determine the survival benefit derived from, and safety of, adding Neuradiab to the current standard of care therapy, consisting of surgery, radiation and adjuvant chemotherapy (temozolomide), for patients diagnosed with primary glioblastoma multiforme. The randomized trial was initiated in July 2008 and will enroll up to 760 patients at leading treatment centers across the United States. Additional information on the trial can be found at http://www.glassarttrial.com or at http://www.clinicaltrials.gov and then by searching the term "Bradmer" or the study identifier NCT00615186.

About Neuradiab(TM)

Neuradiab is a monoclonal antibody, conjugated to radioactive iodine, used to treat gl
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bradmer announces management changes
2. Bradmer provides Phase III Neuradiab trial update and guidance
3. Bradmer to present at Rodman & Renshaw Healthcare Conference
4. Bradmer Medical Isotope Supply For Phase III Trial Secure
5. Bradmer announces additions to Scientific Advisory Board
6. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
7. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
8. Notice of Bradmer Pharmaceuticals Conference Call
9. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
10. Bradmer announces new additions to management team
11. Bradmer announces 2008 first quarter operational and financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... when the spotlight is focused on obesity more than ever, ... associated with weight or certain adverse health risks. According to ... of Nutrition Journal , adults who consume candy at ... overweight nor have greater risk factors for cardiovascular disease (CVD) ... frequent candy eaters (less than 3 times per month).1 ...
(Date:5/20/2013)... Brenda Goodman HealthDay Reporter , , SATURDAY, May ... doctors a better view during colonoscopies may help them ... study shows. Colonoscopies are the recommended screening tests ... killer of men and women in the United States. ... flexible tube with a camera mounted on the end ...
(Date:5/20/2013)... HealthDay Reporter , , SUNDAY, May 19 (HealthDay News) -- ... sleep by endlessly and subconsciously waking them up, becomes ... study raises the possibility that it may somehow cause ... Don,t worry just yet if you have sleep ... there may be no connection between the two conditions. ...
(Date:5/20/2013)... News) -- If you,ve got bunions, chances are others ... with a new study finding the condition is often ... the May issue of Arthritis Care & Research ... inherit conditions such as bunions or other toe deformities. ... heritability of common foot disorders in older adults," Dr. ...
(Date:5/20/2013)... 20, 2013) Research presented at Digestive Disease Week ... with diarrhea (IBS-D) and hepatitis C. , An ... IBS-D. In the phase II study, researchers found that ... 50 percent of the individuals treated. , "While ... IBS with constipation, we haven,t seen the same in ...
Breaking Medicine News(10 mins):Health News:New study suggests candy consumption frequency not linked to obesity or heart disease 2Health News:New study suggests candy consumption frequency not linked to obesity or heart disease 3Health News:New Device May Show Doctors More of the Colon 2Health News:New Device May Show Doctors More of the Colon 3Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 2Health News:Sleep Apnea in Seniors Tied to Alzheimer's in Study 3Health News:Many Can Blame Family for Their Bunions 2Health News:Pharmaceutical advances offer new options for health outcomes 2
... Identifying those at risk for diabetes is important because lifestyle ... the disease. Currently an oral glucose tolerance test is used ... costly and inconvenient. A new study finds a cluster of ... type 2 diabetes independently of other risk factors. ...
... the births of their first two children are more likely to ... have the same partner.// These babies are ... The results are the same even when researchers take into account ... decades of birth. ,Researchers speculate that women who ...
... Commonwealth's restaurants, taverns, and nightclubs, and voted to lift ... House and Senate concluded the year's business with a ... approved a sales tax "holiday" designed to spur shoppers ... economy, and approved $102 million in extra spending for ...
... new study shows a new drug alternative to warfarin in ... The research shows the drug ximelagatran appears to be as ... for people at high risk of stroke because of its ... include an increased risk of bleeding and a possible interaction ...
... promising therapy option may be more effective in treating the ... disease that causes persistent redness on the nose and cheeks. ... to the faces of rosacea sufferers. //The new product contains ... Typically it has a different formula and is used to ...
... is so easily cured that Luvie Owens almost forgot she ... her cause for concern: Women who have had the most ... to also get deadlier cancers such as breast, lung and ... is 7.5 times higher. ,The study didn't include men, ...
Cached Medicine News:Health News:Predictors for Type 2 Diabetes 2Health News:Changing Partners may put Expectant Mothers at Risk 2Health News:Senate assures ban on smoking 2Health News:Senate assures ban on smoking 3Health News:Senate assures ban on smoking 4Health News:People with skin cancer at higher risk for other types , 2
(Date:5/17/2013)... -- Lakeland Industries, Inc. (NASDAQ: LAKE ), a ... and to first responders on the federal, state and ... fiscal 2013 fourth quarter and year ended January 31, ... close and will conduct a conference call on the ... http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call will ...
(Date:5/17/2013)... May 17, 2013   Shareholder rights attorneys  at ... Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed a complaint ... Massachusetts .  The complaint alleges that ... Exchange Act of 1934 (the "Exchange Act") between January ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
(Date:5/17/2013)... May 17, 2013 Research ... and outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces ... presentations at the American Psychiatric Association (APA) 166th Annual ... 18-22. The data being presented represent Shire,s ongoing commitment ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... ANF Group, Inc ., a South Florida based ... 170,000-square-foot Joe DiMaggio Children,s Hospital – the first free ... (Photo: http://photos.prnewswire.com/prnh/20110614/FL18288 ) The hospital,s ... designed to earn Gold Leadership in Energy and Environment ...
... June 14, 2011 CVS/pharmacy provides ... at more than 7,200 convenient locations nationwide. Shoppers have come ... larger-than-ever selection of gifts, goods and everyday needs. From popular ... the hottest gear and thoughtful keepsakes perfect for every dad, ...
Cached Medicine Technology:ANF Group, Inc. Completes New Joe DiMaggio Children's Hospital 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 3
... workmanship are the hallmark of these stereozoom ... mind. The top (incident) circular 9W fluorescent ... while remaining cool to the touch. Binocular ... 10x to 44x zoom magnification or high-power ...
... IR/DIC video camera. Olympus wide array of high-quality ... quality and flexibility you need for an efficient ... real-time image of your specimen that can be ... You can even record movies when these easy-to-operate ...
... is a premium photomicrography system that ... even the most difficult specimens. Designed with ... system provide solution to the complex problem ... automatic exposure control, the system utilizes special ...
... systems for optimum image quality at low ... color digital camera system is specifically designed ... available. State-of-the-art electronics create bright, vibrant images ... dynamic range offered by the Leica cameras ...
Medicine Products: